femara
Pfizer gets early approval for breast cancer drug
February 4, 2015Sales and Marketing FDA, Pfizer, Xalkori (crizotinib), axitinib, bosulif, bosutinib, femara, ibrance, inlyta, letrozole, palbociclib
The FDA has shown Pfizer’s breast cancer drug Ibrance an early green light to treat patients who are at the …
Pfizer to submit breast cancer drug
May 18, 2014Research and Development, Sales and Marketing Pfizer, breast cancer, femara, palbociclib
Pfizer, currently in the middle of trying to acquire AstraZeneca for $106 billion, says it will soon submit its new …
Pfizer breast cancer drug shows promise
February 4, 2014Research and Development, Sales and Marketing Cancer, Pfizer, breast, femara, letrozole, palbociclib
Pfizer’s experimental breast cancer drug palbociclib has successfully extended progression-free survival in a Phase II trial. The pill was administered …
Latest content
